ELRIG Drug Discovery – 2022

ELRIG’s annual Drug Discovery meeting which remains Europe’s largest meeting for life sciences industry professionals. This year our Business Development Executive Tom Ashmore will be heading to London to attend.


4th-5th Oct 2022  

Event type



Tom Ashmore


Tom Ashmore

Business Development Executive

Tom’s focus in Business Development involves identifying new business opportunities and acting as the initial point of contact for companies seeking our cellular and digital pathology services. He is fully conversant in the range of services that HistologiX provides, and using his scientific and legal backgrounds, he discusses and helps design projects to meet our Clients’ analytical goals.

After working in PostDoc research roles with a focus on metabolic programming of obesity, diabetes and ageing, Tom trained in Intellectual Property Law in the pharma and biotech sectors. Tom has a 1st Class honours degree in Biochemistry from the University of Nottingham, and both a Masters and PhD from the University of Cambridge.


Find out more about our services

Stay up to date with HistologiX